ANIMATION

HuLuc 63

PDL BioPharma asked XVIVO to show how a novel humanized antibody, HuLuc 63, appears to induce anti-tumor effects by binding to a protein expressed only on the surface of myeloma cells. This initiates antibody-dependent cytotoxic activity which targets myeloma cells while leaving healthy cells intact.

Project


HuLuc 63


Client


PDL BioPharma

XVIVO really came through for us when we were putting together animations for the Health gallery of the Connecticut Science Center. The beating heart is gorgeous! They are true experts and we really enjoyed collaborating with them.

Shannon Densmore, Executive Producer, Boston Productions, INC.